Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-017624

Director sold 33,244 shares at an average $31.90 ($1,060,518)

From the SEC's structured data for this filing

Trades in this filing

SCHAFFER DAVID · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-27 Sale : show line 1 in the form −13,075 $32.59 $426,076 986,925 D
2021-09-27 Sale : show line 2 in the form −6,157 $33.51 $206,330 980,768 D
2021-09-27 Sale : show line 3 in the form −100 $34.19 $3,419 980,668 D
2021-09-28 Sale : show line 4 in the form −13,812 $30.52 $421,493 966,856 D
2021-09-28 Sale : show line 5 in the form −100 $32.00 $3,200 966,756 D
Open-market sales · 33,244 sh · avg $31.90 · $1,060,518
Loading xslF345X03/doc1.xml…